234 related articles for article (PubMed ID: 36230951)
1. Combination Treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast Cancer Cell Metastasis.
Castro-Guijarro AC; Vanderhoeven F; Mondaca JM; Redondo AL; Zoppino FCM; Fernandez-Muñoz JM; Sanchez AM; Flamini MI
Cells; 2022 Sep; 11(19):. PubMed ID: 36230951
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid induces nuclear FAK translocation and reduces breast cancer cell adhesion through Moesin, FAK, and Paxillin.
Sanchez AM; Shortrede JE; Vargas-Roig LM; Flamini MI
Mol Cell Endocrinol; 2016 Jul; 430():1-11. PubMed ID: 27130522
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor beta.
Flamini MI; Gauna GV; Sottile ML; Nadin BS; Sanchez AM; Vargas-Roig LM
J Cell Mol Med; 2014 Jun; 18(6):1113-23. PubMed ID: 24720764
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Amin S; Matsukuma K; Haque M; Vuligonda V; Chandraratna RA; De Luca LM
Cancer Res; 1999 Jan; 59(1):85-90. PubMed ID: 9892191
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ T cells.
Osipov A; Blair AB; Liberto J; Wang J; Li K; Herbst B; Xu Y; Li S; Niu N; Rashid R; Ding D; Liu Y; Wang Z; Wolfgang CL; Burkhart RA; Laheru D; Zheng L
Cancer Biol Med; 2021 Feb; 18(1):206-214. PubMed ID: 33628595
[TBL] [Abstract][Full Text] [Related]
8. FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth.
Tancioni I; Miller NL; Uryu S; Lawson C; Jean C; Chen XL; Kleinschmidt EG; Schlaepfer DD
Breast Cancer Res; 2015 Mar; 17():47. PubMed ID: 25880415
[TBL] [Abstract][Full Text] [Related]
9. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer.
Provenzano PP; Inman DR; Eliceiri KW; Beggs HE; Keely PJ
Am J Pathol; 2008 Nov; 173(5):1551-65. PubMed ID: 18845837
[TBL] [Abstract][Full Text] [Related]
10. Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy.
Blair AB; Wang J; Davelaar J; Baker A; Li K; Niu N; Wang J; Shao Y; Funes V; Li P; Pachter JA; Maneval DC; Dezem F; Plummer J; Chan KS; Gong J; Hendifar AE; Pandol SJ; Burkhart R; Zhang Y; Zheng L; Osipov A
Gastroenterology; 2022 Nov; 163(5):1267-1280.e7. PubMed ID: 35718227
[TBL] [Abstract][Full Text] [Related]
11. Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.
Walsh C; Tanjoni I; Uryu S; Tomar A; Nam JO; Luo H; Phillips A; Patel N; Kwok C; McMahon G; Stupack DG; Schlaepfer DD
Cancer Biol Ther; 2010 May; 9(10):778-90. PubMed ID: 20234193
[TBL] [Abstract][Full Text] [Related]
12. All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action.
Mezquita B; Mezquita P; Pau M; Gasa L; Navarro L; Samitier M; Pons M; Mezquita C
Sci Rep; 2018 May; 8(1):7047. PubMed ID: 29728589
[TBL] [Abstract][Full Text] [Related]
13. Black rice-derived anthocyanins inhibit HER-2-positive breast cancer epithelial-mesenchymal transition-mediated metastasis in vitro by suppressing FAK signaling.
Zhou J; Zhu YF; Chen XY; Han B; Li F; Chen JY; Peng XL; Luo LP; Chen W; Yu XP
Int J Mol Med; 2017 Dec; 40(6):1649-1656. PubMed ID: 29039492
[TBL] [Abstract][Full Text] [Related]
14. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
Golubovskaya VM; Virnig C; Cance WG
Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
[TBL] [Abstract][Full Text] [Related]
15. Protein Kinase C Alpha (PKCα) overexpression leads to a better response to retinoid acid therapy through Retinoic Acid Receptor Beta (RARβ) activation in mammary cancer cells.
Bessone MID; Berardi DE; Cirigliano SM; Delbart DI; Peters MG; Todaro LB; Urtreger AJ
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3241-3253. PubMed ID: 32865619
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RARalpha-dependent signaling pathway.
López-Boado YS; Klaus M; Dawson MI; López-Otín C
J Biol Chem; 1996 Dec; 271(50):32105-11. PubMed ID: 8943263
[TBL] [Abstract][Full Text] [Related]
17. Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts.
Anbalagan M; Ali A; Jones RK; Marsden CG; Sheng M; Carrier L; Bu Y; Hangauer D; Rowan BG
Mol Cancer Ther; 2012 Sep; 11(9):1936-47. PubMed ID: 22784709
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression.
Ward KK; Tancioni I; Lawson C; Miller NL; Jean C; Chen XL; Uryu S; Kim J; Tarin D; Stupack DG; Plaxe SC; Schlaepfer DD
Clin Exp Metastasis; 2013 Jun; 30(5):579-94. PubMed ID: 23275034
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R
Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
Mitra SK; Lim ST; Chi A; Schlaepfer DD
Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]